Who holds BIOLASE's stock?
BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), today announced that it held its annual meeting of stockholders on April 28, 2022 where …
Where can I buy Biol shares?
Apr 17, 2022 · BIOLASE's stock was trading at $14.50 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, BIOL shares have decreased by 65.0% and is now trading at $5.08. View which stocks have been most impacted by COVID-19.
What are analysts'price targets for BIOLASE's stock?
May 05, 2022 · Real-time trade and investing ideas on Biolase Inc BIOL from the largest community of traders and investors.
When is BIOLASE's special meeting of stockholders?
Apr 28, 2022 · The Biolase stock price fell by -34.20% on the last day (Thursday, 28th Apr 2022) from $0.30 to $0.20. During the day the stock fluctuated 52.10% from a day low at $0.20 to a day high of $0.30. The price has fallen in 5 of the last 10 days and is down by -37.62% for this period. Volume has increased on the last day by 8 million shares but on ...
Is Biol stock a good investment?
What does Biol company do?
Will biolase be delisted?
Is waterlase FDA approved?
Is biolase a good company?
Is Biol doing a reverse split?
Is BIOLASE a buy right now?
2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for BIOLASE in the last year. There are currently 2 buy rati...
How has BIOLASE's stock price been impacted by COVID-19?
BIOLASE's stock was trading at $0.58 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since th...
Are investors shorting BIOLASE?
BIOLASE saw a decline in short interest during the month of February. As of February 15th, there was short interest totaling 4,440,000 shares, a de...
When is BIOLASE's next earnings date?
BIOLASE is scheduled to release its next quarterly earnings announcement on Thursday, March 17th 2022. View our earnings forecast for BIOLASE .
How can I listen to BIOLASE's earnings call?
BIOLASE will be holding an earnings conference call on Thursday, March 17th at 4:30 PM Eastern. Interested parties can register for or listen to th...
How were BIOLASE's earnings last quarter?
BIOLASE, Inc. (NASDAQ:BIOL) issued its quarterly earnings data on Wednesday, November, 10th. The medical technology company reported ($0.02) EPS fo...
When did BIOLASE's stock split? How did BIOLASE's stock split work?
Shares of BIOLASE reverse split on the morning of Friday, May 11th 2018. The 1-5 reverse split was announced on Thursday, May 10th 2018. The number...
What guidance has BIOLASE issued on next quarter's earnings?
BIOLASE issued an update on its fourth quarter 2021 earnings guidance on Monday, February, 7th. The company provided earnings per share (EPS) guida...
What price target have analysts set for BIOL?
2 brokers have issued 12-month price objectives for BIOLASE's stock. Their forecasts range from $2.00 to $3.00. On average, they expect BIOLASE's s...
Is BIOLASE a buy right now?
What stocks does MarketBeat like better than BIOLASE?
3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for BIOLASE in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" BIOLASE stock.#N#View analyst ratings for BIOLASE or view top-rated stocks.
When is BIOLASE's next earnings date?
Wall Street analysts have given BIOLASE a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but BIOLASE wasn't one of them.
How were BIOLASE's earnings last quarter?
BIOLASE is scheduled to release its next quarterly earnings announcement on Thursday, November 11th 2021.#N#View our earnings forecast for BIOLASE.
How has BIOLASE's stock price been impacted by COVID-19 (Coronavirus)?
BIOLASE, Inc. (NASDAQ:BIOL) issued its quarterly earnings results on Wednesday, August, 11th. The medical technology company reported ($0.02) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.04) by $0.02.
When did BIOLASE's stock split? How did BIOLASE's stock split work?
BIOLASE's stock was trading at $0.58 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, BIOL stock has increased by 25.2% and is now trading at $0.7260.#N#View which stocks have been most impacted by COVID-19.
What guidance has BIOLASE issued on next quarter's earnings?
BIOLASE's stock reverse split before market open on Friday, May 11th 2018. The 1-5 reverse split was announced on Thursday, May 10th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, May 10th 2018.
Signals & Forecast
BIOLASE issued an update on its third quarter 2021 earnings guidance on Thursday, September, 2nd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $9.13 million-$9.13 million, compared to the consensus revenue estimate of $8.88 million.
Support, Risk & Stop-loss
The Biolase stock holds a sell signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock.
Is Biolase stock A Buy?
Biolase finds support from accumulated volume at $0.67 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
Biolase, Inc. (BIOL)
Biolase holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Style Scorecard
This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
Chart for BIOL
The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.
Zacks' 7 Best Strong Buys for September, 2021
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
ETFs
Zacks has a proven record of recommending stocks with major upside potential. This report reveals 7 stocks predicted to have explosive gains over the next 30-90 days. A recent pick, Fiverr, spiked +84.6% in just 30 days. In today's bull market, these stocks could climb even higher. See our 7 Best Stocks absolutely FREE.
Mutual Funds
The biotech space has once again come under the spotlight as the FDA has granted the first full U.S. approval to Pfizer...
Options
The expanding volume of data and the need to analyze it for business boost will spur a higher uptake of big data.
Recently Viewed Tickers
Market participants are taking on a 'this is as good as it gets' mentality, and it may be time to think about hedging your...
Biolase Inc
Visit a quote page and your recently viewed tickers will be displayed here.
